JustinRichardBaileyMD
Infectious Disease • Baltimore, MDAssistant Professor of Medicine, Johns Hopkins University School of Medicine
Dr. Bailey is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1717 E Monument St
Baltimore, MD 21287Phone+1 410-955-1725Fax+1 410-500-4266
Education & Training
Johns Hopkins UniversityFellowship, Infectious Disease, 2009 - 2012
Massachusetts General HospitalResidency, Internal Medicine, 2007 - 2010- Johns Hopkins University School of MedicineClass of 2007
Certifications & Licensure
MD State Medical License 2010 - 2026
American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Publications & Presentations
PubMed
- Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivity.Parker J Jamieson, Xiaoying Shen, Alexandra A Abu-Shmais, Perry T Wasdin, Katarzyna Janowska
Biorxiv. 2025-01-20 - 2 citationsRecombinant H77C gpE1/gpE2 heterodimer elicits superior HCV cross-neutralisation than H77C gpE2 alone.Juthika Kundu, Hoa T Le, Michael Logan, Darren Hockman, Abdolamir Landi
Journal of Hepatology. 2024-12-01 - 3 citationsConvergent evolution and targeting of diverse E2 epitopes by human broadly neutralizing antibodies are associated with HCV clearance.Clinton O Ogega, Nicole E Skinner, Marta V Schoenle, Xander E Wilcox, Nicole Frumento
Immunity. 2024-04-09
Journal Articles
- CMPK2 and BCL-G Are Associated with Type 1 Interferon–Induced HIV Restriction in HumansJustin R. Bailey, Joel N. Blankson, Robert F. Siliciano, Stuart C. Ray, Ramy El-Diwany, Science Magazine
Grant Support
- Molecular and structural characterization of broadly neutralizing anti-HCV antibodiesJOHNS HOPKINS UNIVERSITY2023–2028
- Molecular and structural characterization of broadly neutralizing anti-HCV antibodiesJOHNS HOPKINS UNIVERSITY2023–2028
- The role of neutralizing antibodies in natural and treatment-induced control of hepatitis B with and without HIV-1 co-infectionJOHNS HOPKINS UNIVERSITY2023–2027
- The role of neutralizing antibodies in natural and treatment-induced control of hepatitis B with and without HIV-1 co-infectionJOHNS HOPKINS UNIVERSITY2023–2027
- Neutralizing antibody responses during natural control of acute hepatitis B with and without HIV-1 coinfectionJOHNS HOPKINS UNIVERSITY2022–2026
- Development of standardized immunoassays and virus panels for HCV vaccine researchJOHNS HOPKINS UNIVERSITY2021–2025
Other Languages
- German
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/justin-bailey
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
